Wellington Management Private Investing

Are higher interest rates a unicorn killer? In this article, William C. and Mark Watson, members of our late-stage private equity team, share their observations on the growing importance of investing in private companies with durable fundamentals, particularly capital efficiency. Unicorns may be even rarer, but they could be stronger (and more believable) than ever.

In our private market outlook collection, we explore the themes driving the rapid evolution of private credit and private equity markets.

Venture capital markets have a "growing emphasis on capital efficiency." Dive deeper into this and 7 other emerging #VC trends in our 2024 mid-year outlook.

Congratulations to Shanna O'Reilly, Wellington’s co-head of private investments, for being named to GrowthCap’s “Top Women Leaders in Growth Investing of 2024” list! This recognition highlights her impact building Wellington’s global private investing business and her mentorship both within our firm and across the industry. https://lnkd.in/ekba4DkQ Wellington Management did pay a fee to be considered. The selection of winners was carried out through a nomination process that involved reviewing feedback from colleagues, portfolio company executives, and others in the industry for each nominee. The evaluation of each candidate was based on factors such as their success in their roles, the breadth of their experience, their longevity in the field, and their consistent performance. This award was announced on June 18, 2024 and was based on information provided in our submission as of January 2024. The award may not be representative of any one client’s experience. The award is not indicative of Wellington Management’s future performance. Past performance is no guarantee of future results.

We’re pleased to share that we led GrayMatter Robotics' $45M Series B funding. This funding supports their AI-powered robotics solutions, which help address key manufacturing challenges of throughput, quality and efficiency. Our firm is proud to support GrayMatter’s growth and innovation. Read more about Graymatter: https://lnkd.in/dZ9RRE-f

🎥 📢 Watch Jean Hynes speak to Leslie Picker from CNBC Squawk Box from the SuperReturn International event in Berlin on the state of private credit, finding opportunities in the space, macro outlook and more. https://lnkd.in/erKiKfMD #SuperReturn #alternatives #privateequity

Great discussion during the Keynote panel ‘How have PE markets evolved over the past few years and what are the new key drivers of growth across market cycles?' at the SuperReturn International Conference 2024 with Wellington's Matthew Witheiler and fellow panelists and moderator John Romeo, Oliver Wyman. At Wellington, we consider the private market from multiple angles. Learn more on our private investing capabilities. https://lnkd.in/e_wvMfwN #SuperReturn #alternatives #privateequity For professional or institutional investors only. Capital at risk.

We're proud to celebrate Sector Lead, Matthew Witheiler's fourth consecutive naming to Forbes’ ‘The Midas List: The World’s Best Venture Capital Investors in 2024'. Congratulations, Matt, on this remarkable achievement - which is a testament to your enduring impact on the late-stage VC industry. https://lnkd.in/e36JXx_v Wellington Management did not pay a fee to be considered. Winners were selected by a data-driven approach, the Midas List is produced from a combination of public data sources and the submissions of hundreds of investment partners across hundreds of firms each year. This award was announced on June 4, 2024, a submission made in January 2024 and is based on 5 years of trailing data. The award may not be representative of any one client’s experience. The award is not indicative of Wellington Management’s future performance. Past performance is no guarantee of future results.

We’re excited to be part of the delegation team from Wellington Management at the SuperReturn International Conference 2024. Matthew Witheiler, Sector Lead, Consumer & Technology, Nilesh Kumar, Head of Biotech Private Investments, and our Alternatives Directors Camiel de Vries, Christopher Farrell, CFA, Kalyani Harar, and Helena Black (née O'Connell) and Stacey Willoughby welcome the opportunity to connect with you on a wide range of topics across our private investing platform. 🇩🇪 🥨 👏 Secure one of the remaining slots left to meet with members of the delegation team onsite. https://lnkd.in/eSe5nPdZ #SuperReturn #alternatives #privateequity For professional or institutional investors only. Capital at risk.

Which characteristics signal durability in a health care startup? Which characteristics are red flags for private equity investors? Two members of our late-stage growth team, health care sector lead Joshua Sommerfeld and venture associate Jahon Rafian, share insights and results from their recent research and analysis of enterprise-value trajectories for private, non-biotech health care companies.